Condition: Articular Cartilage Defects in the Knee Joint · Sponsor: Histogenics Corporation
This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Tucson Orthopaedic Institute | Tucson, Arizona, United States | — |
| Grossmont Orthopedic Medical Group | La Mesa, California, United States | — |
| Orthopaedic Specialty Institute/Newport Orthopedic Institute (OSI/NOI) | Orange, California, United States | — |
| UCSF Mission Bay Orthopaedic Institute | San Francisco, California, United States | — |
| Southern California Orthopedic Research and Education | Van Nuys, California, United States | — |
| Colorado University Boulder | Boulder, Colorado, United States | — |
| Steadman Hawkins Clinic - Denver | Denver, Colorado, United States | — |
| Shrock Clinical Research | Fort Lauderdale, Florida, United States | — |
| Jewett Orthopaedic Clinic | Orlando, Florida, United States | — |
| Optim Healthcare | Savannah, Georgia, United States | — |
| St. Lukes Medical Center | Boise, Idaho, United States | — |
| Rush University Medical Center | Chicago, Illinois, United States | — |
+ 19 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01066702